Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Simpson

Showing results (301-310 of 310) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 310 results.
The Lancet. Respiratory Medicine|December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Critical Care Medicine|January 5, 2021
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and RecoveryAllison Tong, Amanda Baumgart, Nicole Evangelidis, et al.
Nature Immunology|May 27, 2022
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammationAnanda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
Nature Immunology|July 19, 2022
Author Correction: Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammationAnanda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
Nature Medicine|April 21, 2021
Single-cell multi-omics analysis of the immune response in COVID-19Emily Stephenson, Gary Reynolds, Rachel A Botting, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Children must be protected from the tobacco industry's marketing tacticsNicholas Hopkinson, Colin Wallis, Bernard Higgins, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 31

Showing results (301-310 of 310) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
The Lancet. Respiratory Medicine|December 8, 2019
Biomarker-guided antibiotic stewardship in suspected ventilator-associated pneumonia (VAPrapid2): a randomised controlled trial and process evaluationThomas P Hellyer, Daniel F McAuley, Timothy S Walsh, et al.
Critical Care Medicine|January 5, 2021
Core Outcome Measures for Trials in People With Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and RecoveryAllison Tong, Amanda Baumgart, Nicole Evangelidis, et al.
Nature Immunology|May 27, 2022
Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammationAnanda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
Nature Immunology|July 19, 2022
Author Correction: Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammationAnanda S Mirchandani, Stephen J Jenkins, Calum C Bain, et al.
BMJ Open Respiratory Research|September 24, 2021
Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)Jim M Wild, Joanna C Porter, Philip L Molyneaux, et al.
ERJ Open Research|January 16, 2024
Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UKGiles Dixon, Samuel Hague, Sarah Mulholland, et al.
Nature Medicine|April 21, 2021
Single-cell multi-omics analysis of the immune response in COVID-19Emily Stephenson, Gary Reynolds, Rachel A Botting, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2022
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post-COVID-19 StudyIain Stewart, Joseph Jacob, Peter M George, et al.
BMJ (Clinical Research Ed.)|December 11, 2013
Children must be protected from the tobacco industry's marketing tacticsNicholas Hopkinson, Colin Wallis, Bernard Higgins, et al.
Diagnostic and Prognostic Research|May 17, 2019
Erratum to: Methods for evaluating medical tests and biomarkersGowri Gopalakrishna, Miranda Langendam, Rob Scholten, et al.
Pageof 31